Kirk Hou, MD
Retina Specialist · Los Angeles, CANPI 1962883025
Payments from drug & device makers
Across 47 payments — averaging $200.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Optovue, Inc.$1K
- Alcon$683
- Novartis$245
- Apellis Pharmaceuticals, Inc.$195
- Glaukos Corporation$166
- plus $183 from 3 others
What the payments were for
- Consulting fees$5,77261%
- Travel & lodging$1,34814%
- Food & beverage$2,28924%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $6,798 |
| Optovue, Inc. | 1 | $1,140 |
| Alcon | 5 | $683 |
| Novartis | 2 | $245 |
| Apellis Pharmaceuticals, Inc. | 2 | $195 |
| Glaukos Corporation | 1 | $166 |
| Regeneron Healthcare Solutions, Inc. | 3 | $84 |
| Astellas Pharma US Inc | 2 | $67 |
| Bausch & Lomb Americas Inc. | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,409 in reported general payments places this provider in the 60th percentile of 187 retina specialist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 91 | $5,158 |
| Difluprednate | 30 | $2,220 |
| Ketorolac Tromethamine | 62 | $1,448 |
| Brimonidine Tartrate | 20 | $1,075 |
| Atropine Sulfate | 30 | $1,020 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 36 | $751 |
| MoxifloxacinMoxifloxacin Hcl | 20 | $560 |
| Latanoprost | 15 | $83 |
| Timolol Maleate | 12 | $31 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Los Angeles
- Daniel SuLos Angeles$103K
- David LazarLos Angeles$22K
- Dante PieramiciSanta Barbara$15.1M
- Margaret ChangSacramento$13.2M
- Hani Salehi-HadHuntington Beach$12.2M
- Payam AminiPasadena$9.9M
- Joel PearlmanSacramento$8.3M
- Dilsher DhootSanta Barbara$8.2M
- Ashkan PirouzFullerton$6.9M
- Roger GoldbergWalnut Creek$5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.